Nextnode Bioscience Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-12-2024
- Paid Up Capital ₹ 1.10 M
as on 10-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 10-12-2024
- Revenue 581.92%
(FY 2020)
- Profit -25.80%
(FY 2020)
- Ebitda 82.04%
(FY 2020)
- Net Worth 8.73%
(FY 2020)
- Total Assets 54.25%
(FY 2020)
About Nextnode Bioscience
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Sunny Patel and Jigarkumar Patel serve as directors at the Company.
- CIN/LLPIN
U36995GJ2018PTC101865
- Company No.
101865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nextnode Bioscience Private Limited offer?
Nextnode Bioscience Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Organic Fertilizers and Manure.
Who are the key members and board of directors at Nextnode Bioscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunny Patel  | Director | 14-Nov-2018 | Current |
| Jigarkumar Patel | Director | 14-Aug-2018 | Current |
Financial Performance of Nextnode Bioscience.
Nextnode Bioscience Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 581.92% increase. The company also saw a substantial fall in profitability, with a 25.8% decrease in profit. The company's net worth moved up by a moderate rise of 8.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nextnode Bioscience?
Unlock access to Nextnode Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 May 2020 | ₹2.00 Cr | Open |
How Many Employees Work at Nextnode Bioscience?
Unlock and access historical data on people associated with Nextnode Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nextnode Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextnode Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
